This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Cepheid Corporation. Active years: 2019-2024.
Company Filing History:
Years Active: 2019-2024
Title: Leena McCann: Innovator in Bladder Cancer Detection
Introduction
Leena McCann is a prominent inventor based in Santa Clara, CA (US). She has made significant contributions to the field of medical diagnostics, particularly in the detection of bladder cancer. With a total of 2 patents, her work is paving the way for advancements in cancer detection methods.
Latest Patents
Leena's latest patents focus on innovative methods for detecting bladder cancer. These patents provide compositions and methods for identifying bladder cancer, including low-grade variants. Additionally, they offer techniques for monitoring the recurrence of bladder cancer. The methods involve detecting androgen receptor (AR) and/or uroplakin 1B (UPK1B), which are crucial biomarkers in the diagnosis and management of this disease.
Career Highlights
Leena McCann is currently associated with Cepheid Corporation, where she applies her expertise in medical diagnostics. Her work at Cepheid has been instrumental in developing cutting-edge technologies that enhance the accuracy and efficiency of cancer detection.
Collaborations
Leena collaborates with talented professionals in her field, including Stacey Ellen Wallace and Russell G Higuchi. These partnerships foster innovation and contribute to the advancement of medical technologies.
Conclusion
Leena McCann's contributions to bladder cancer detection exemplify her commitment to improving healthcare through innovation. Her patents and work at Cepheid Corporation highlight her role as a leading inventor in the medical field.